TETRASPAN

This brand name is authorized in Ecuador, Estonia, Hong Kong, Lithuania, Poland, Singapore, South Africa

Active ingredients

The drug TETRASPAN contains a combination of these active pharmaceutical ingredients (APIs):

1 Poly (0-2-hydroxyethyl) starch (M.W 200000)
UNII 1GVO236S58 - HYDROXYETHYL STARCH 130/0.4
Read about HAES
2 Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE

Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue.

Read about Sodium chloride
3 Potassium chloride
UNII 660YQ98I10 - POTASSIUM CHLORIDE

Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism.

Read about Potassium chloride
4 Calcium chloride dihydrate
UNII M4I0D6VV5M - CALCIUM CHLORIDE

Calcium is the most abundant mineral in the body, and is an essential body electrolyte. Homeostasis is mainly regulated by the parathyroid hormone, by calcitonin, and by the activated form of vitamin D. Calcium is a structural component of bones and teeth. It is also required for blood clotting, neurotransmitter release, muscle contraction and normal heartbeat.

Read about Calcium chloride
5 Magnesium chloride hexahydrate
UNII 02F3473H9O - MAGNESIUM CHLORIDE
Read about Magnesium chloride
6 Sodium acetate trihydrate
UNII 4550K0SC9B - SODIUM ACETATE
Read about Sodium acetate
7 Malic acid
UNII 817L1N4CKP - MALIC ACID
Read about Malic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B05AA07 Hydroxyethylstarch B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions
Discover more medicines within B05AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): H5080513
Country: EE Ravimiamet Identifier(s): 1244258, 1244270, 1244281, 1244304, 1244326, 1244337
Country: HK Department of Health Drug Office Identifier(s): 56978, 56979
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1022925, 1025813, 1025815
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100175601, 100175618
Country: SG Health Sciences Authority Identifier(s): 14017P, 14018P
Country: ZA Health Products Regulatory Authority Identifier(s): 42/8.4/0993, 42/8.4/0994

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.